Bayer AG faces a $100 million jury verdict over PCB exposure at a Seattle school amid ongoing legal challenges related to ...

An example of chemical shift imaging of the mouse brain acquired via BioSpec Maxwell ... and neurotransmitter concentrations in neurological disorders. Built upon metabolic signatures, CEST ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

Wealth Enhancement Advisory Services LLC grew its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 1 ...

Dr. Beaurang was part of the founding team of Five Prime Therapeutics (NSDQ: FPRX acquired by Amgen), an oncology and ... and target validation for a variety of malignant and neurological diseases.

Accurate Wealth Management LLC acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during the ...

Toddlers may sometimes encounter pauses in speech and some levels of disfluencies while speaking, which is a normal aspect of ...

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 billion, boosting its presence in the market for neurological disorder treatments. J&J will buy all of ...

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 billion, boosting its ...

Explore the applications of preclinical MRI in neurological diseases, focusing on functional and metabolic imaging techniques ...

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges projected by 2026-2028.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.